Celularity Inc. Extends Promissory Note Maturity, Issues 100,000 Shares with Piggyback Registration Rights

Reuters
21 May
<a href="https://laohu8.com/S/CELU">Celularity Inc.</a> Extends Promissory Note Maturity, Issues 100,000 Shares with Piggyback Registration Rights

Celularity Inc. has announced a strategic agreement with YA II PN, Ltd. that includes the issuance of 100,000 shares of the company's restricted common stock. This move comes as part of an arrangement to extend the maturity date of a Convertible Promissory Note originally dated March 13, 2024, from May 12, 2025, to August 15, 2025. The newly issued shares will have piggyback registration rights, allowing for their resale to be included in any future registration statement filed by Celularity Inc.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Celularity Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001641172-25-011751), on May 20, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10